Research (Jan 2023)

Restoration of Motor Function through Delayed Intraspinal Delivery of Human IL-10-Encoding Nucleoside-Modified mRNA after Spinal Cord Injury

  • László Gál,
  • Tamás Bellák,
  • Annamária Marton,
  • Zoltán Fekécs,
  • Drew Weissman,
  • Dénes Török,
  • Rachana Biju,
  • Csaba Vizler,
  • Rebeka Kristóf,
  • Mitchell B. Beattie,
  • Paulo J.C. Lin,
  • Norbert Pardi,
  • Antal Nógrádi,
  • Krisztián Pajer

DOI
https://doi.org/10.34133/research.0056
Journal volume & issue
Vol. 6

Abstract

Read online

Efficient in vivo delivery of anti-inflammatory proteins to modulate the microenvironment of an injured spinal cord and promote neuroprotection and functional recovery is a great challenge. Nucleoside-modified messenger RNA (mRNA) has become a promising new modality that can be utilized for the safe and efficient delivery of therapeutic proteins. Here, we used lipid nanoparticle (LNP)-encapsulated human interleukin-10 (hIL-10)-encoding nucleoside-modified mRNA to induce neuroprotection and functional recovery following rat spinal cord contusion injury. Intralesional administration of hIL-10 mRNA-LNP to rats led to a remarkable reduction of the microglia/macrophage reaction in the injured spinal segment and induced significant functional recovery compared to controls. Furthermore, hIL-10 mRNA treatment induced increased expression in tissue inhibitor of matrix metalloproteinase 1 and ciliary neurotrophic factor levels in the affected spinal segment indicating a time-delayed secondary effect of IL-10 5 d after injection. Our results suggest that treatment with nucleoside-modified mRNAs encoding neuroprotective factors is an effective strategy for spinal cord injury repair.